- Home
- VIGL vs SFWL Comparison
VIGL vs SFWL Comparison
Compare VIGL & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- SFWL
- Stock Information
- Founded
- VIGL 2020
- SFWL 2001
- Country
- VIGL United States
- SFWL China
- Employees
- VIGL N/A
- SFWL N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- SFWL Trucking Freight/Courier Services
- Sector
- VIGL Health Care
- SFWL Industrials
- Exchange
- VIGL Nasdaq
- SFWL Nasdaq
- Market Cap
- VIGL 134.9M
- SFWL 81.0M
- IPO Year
- VIGL 2022
- SFWL 2023
- Fundamental
- Price
- VIGL $7.99
- SFWL $1.01
- Analyst Decision
- VIGL Buy
- SFWL
- Analyst Count
- VIGL 7
- SFWL 0
- Target Price
- VIGL $8.00
- SFWL N/A
- AVG Volume (30 Days)
- VIGL 1.6M
- SFWL 10.7K
- Earning Date
- VIGL 08-12-2025
- SFWL 07-15-2025
- Dividend Yield
- VIGL N/A
- SFWL N/A
- EPS Growth
- VIGL N/A
- SFWL 4.79
- EPS
- VIGL N/A
- SFWL 0.13
- Revenue
- VIGL N/A
- SFWL $504,158,000.00
- Revenue This Year
- VIGL N/A
- SFWL N/A
- Revenue Next Year
- VIGL N/A
- SFWL N/A
- P/E Ratio
- VIGL N/A
- SFWL $7.66
- Revenue Growth
- VIGL N/A
- SFWL 24.75
- 52 Week Low
- VIGL $1.31
- SFWL $0.86
- 52 Week High
- VIGL $8.00
- SFWL $1.60
- Technical
- Relative Strength Index (RSI)
- VIGL 88.87
- SFWL 54.91
- Support Level
- VIGL $7.86
- SFWL $0.91
- Resistance Level
- VIGL $7.96
- SFWL $1.02
- Average True Range (ATR)
- VIGL 0.02
- SFWL 0.05
- MACD
- VIGL -0.18
- SFWL 0.00
- Stochastic Oscillator
- VIGL 93.33
- SFWL 90.91
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.